One of the greatest offerings we give as an e-signature company is the ability to reduce the amount of paper and precious time it takes for a clinical trial to go to market. On Tuesday, December 1 at 1:00 p.m. EST, SIGNiX will partner with the Society for Clinical Research Sites to present an informational webinar.Read More
Life Sciences News
As the only e-signature vendor exhibiting during the Global Site Solutions Summit, SIGNiX had the unique opportunity to collect every detail of the needs of clinical investigative sites. Global Site Solutions Summit, a conference to advance the ethical and efficient conduct of clinical research and to encourage and build strong site partnerships, was held in Amelia Island, Florida October 8-11.Read More
SIGNiX traveled to Boston this month to exhibit at Dpharm’s Disruptive Innovations Conference for Life Sciences. Disruptive Innovations is about creating efficiency and utilizing technology within the Life Sciences industry.Read More
SIGNiX is excited to be a part of a conference that is bringing innovations to the Life Sciences community. This year, we will be joining the 5th annual DPharm: Disruptive Innovations to Advance Clinical Trials conference to aid in the advance of clinical trials by speeding up the signature process and cutting down on the cost of paper processes.Read More
It was a great year to attend DIA’s 2015 Annual Meeting, an event that unites life sciences professionals with the shared goal of nurturing innovation. We had the chance to travel to our nation’s capitol and exhibit at the event. Here are our key takeaways from the conference:Read More
We are excited to announce that we are a “20 Most Promising Pharma and Life Sciences Technology Solution Provider in 2015” selected by CIOReview.
This annual list showcases the best vendors and consultants who provide top technology solutions to these industries. A panel of experts and members of CIOReview’s editorial board select companies for the list, and SIGNiX is honored to be recognized.Read More
In many years dealing with Part 11 compliance, I have often seen confusion over exactly what constitutes an “Electronic Signature.” The FDA’s definition is found in 21 CFR Part 11; Electronic Records, Electronic Signatures, the regulations specifying the FDA’s requirements for using records and signatures in electronic form to meet the record-keeping requirements of Agency regulations in the Life Sciences industry.Read More
Tags: 21 CFR Part 11
We’re happy to announce that this week we launched PharmaDoX—the pharmaceutical industry’s first digital signature service created specifically to relieve the paperwork burdens of clinical trials. With PharmaDoX, it’s easy for sponsors, clinical research organizations (CROs), patients and investigators to sign clinical trial documents. This ready-made solution incorporates all the requirements of the FDA’s 21 CFR Part 11 rule by default.Read More
The benefits of digital signatures for the life sciences industry are undeniable. Clinical research organizations (CROs) are drawn to the incredible cost savings opportunity—one clinical research institute is able to save $1 million per year on postage by switching to digital signatures. CROs and pharmaceutical companies also appreciate the assurance that every consent form will be returned 100% complete in a fraction of the time of a paper process.Read More
Tags: credit unions
Last month, we announced a new partnership with SAFE-BioPharma to create a compliant solution for the biopharmaceutical industry. This relationship is part of our ongoing commitment to offer the most secure and compliant digital signature product on the market. In response to our announcement, many people have asked us for more information about SAFE-BioPharma and their digital signature standard, and we’re here to help.